Highly birefringent microstructured optical fiber for distributed hydrostatic pressure sensing with sub-bar resolution.

We demonstrate distributed optical fiber-based pressure measurements with sub-bar pressure resolution and 1 m spatial resolution over a ∼100 m distance using a phase-sensitive optical time-domain reflectometry technique. To do so, we have designed a novel highly birefringent microstructured optical fiber that features a high pressure to temperature sensitivity ratio, a high birefringence and a mode field diameter that is comparable to that of conventional step-index single mode fibers. Our experiments with two fibers fabricated according to the design confirm the high polarimetric pressure sensitivities (-62.4 rad×MPa-1×m-1 and -40.1 rad×MPa-1×m-1) and simultaneously low polarimetric temperature sensitivities (0.09 rad×K-1×m-1 and 0.2 rad×K-1×m-1), at a wavelength of 1550 nm. The fiber features a sufficiently uniform birefringence over its entire length (2.17×10-4 ± 7.65×10-6) and low propagation loss (∼3 dB/km), which allows envisaging pressure measurements along distances up to several kilometers.

Long-distance distributed pressure sensing based on frequency-scanned phase-sensitive optical time-domain reflectometry.

In this paper, a long-distance distributed pressure sensing system based on a special fiber and using frequency-scanned phase-sensitive optical time-domain reflectometry is proposed. The fiber shows high pressure sensitivity (159 MHz/bar) and low loss (3 dB/km) owing to its simple structure made of two large air holes in the cladding. The pressure response of the two orthogonal polarization axes of the fiber is explored distinctively. Distributed pressure sensing over a long sensing range (720 m) and high spatial resolution (5 cm) is demonstrated, resulting in 14,400 resolved sensing points with uncertainty on pressure of 0.49 bar. Discrimination between the temperature/strain and pressure responses is demonstrated, taking advantage of the different pressure and temperature sensitivities of the two polarization axes. In addition, the temperature response of the fiber is studied and the simulation results show the possibility of scaling the temperature sensitivity by adjusting the size of the core. The sensing distance limit due to crosstalk between the polarization axes is also discussed.

Incorporating high-resolution climate, remote sensing and topographic data to map annual forest growth in central and eastern Europe.

To enhance our understanding of forest carbon sequestration, climate change mitigation and drought impact on forest ecosystems, the availability of high-resolution annual forest growth maps based on tree-ring width (TRW) would provide a significant advancement to the field. Site-specific characteristics, which can be approximated by high-resolution Earth observation by satellites (EOS), emerge as crucial drivers of forest growth, influencing how climate translates into tree growth. EOS provides information on surface reflectance related to forest characteristics and thus can potentially improve the accuracy of forest growth models based on TRW. Through the modelling of TRW using EOS, climate and topography data, we showed that species-specific models can explain up to 52 % of model variance (Quercus petraea), while combining different species results in relatively poor model performance (R2 = 13 %). The integration of EOS into models based solely on climate and elevation data improved the explained variance by 6 % on average. Leveraging these insights, we successfully generated a map of annual TRW for the year 2021. We employed the area of applicability (AOA) approach to delineate the range in which our models are deemed valid. The calculated AOA for the established forest-type models was 73 % of the study region, indicating robust spatial applicability. Notably, unreliable predictions predominantly occurred in the climate margins of our dataset. In conclusion, our large-scale assessment underscores the efficacy of combining climate, EOS and topographic data to develop robust models for mapping annual TRW. This research not only fills a critical void in the current understanding of forest growth dynamics but also highlights the potential of integrated data sources for comprehensive ecosystem assessments.

Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.

INTRODUCTION: Performance status (PS) 2 patients with non-small cell lung cancer (NSCLC) experience more toxicity, lower response rates, and shorter survival times than healthier patients treated with standard chemotherapy. Paclitaxel poliglumex (PPX), a macromolecule drug conjugate of paclitaxel and polyglutamic acid, reduces systemic exposure to peak concentrations of free paclitaxel and may lead to increased concentrations in tumors due to enhanced vascular permeability. METHODS: Chemotherapy-naive PS 2 patients with advanced NSCLC were randomized to receive carboplatin (area under the curve = 6) and either PPX (210 mg/m/10 min without routine steroid premedication) or paclitaxel (225 mg/m/3 h with standard premedication) every 3 weeks. The primary end point was overall survival. RESULTS: A total of 400 patients were enrolled. Alopecia, arthralgias/myalgias, and cardiac events were significantly less frequent with PPX/carboplatin, whereas grade > or =3 neutropenia and grade 3 neuropathy showed a trend of worsening. There was no significant difference in the incidence of hypersensitivity reactions despite the absence of routine premedication in the PPX arm. Overall survival was similar between treatment arms (hazard ratio, 0.97; log rank p = 0.769). Median and 1-year survival rates were 7.9 months and 31%, for PPX versus 8 months and 31% for paclitaxel. Disease control rates were 64% and 69% for PPX and paclitaxel, respectively. Time to progression was similar: 3.9 months for PPX/carboplatin versus 4.6 months for paclitaxel/carboplatin (p = 0.210). CONCLUSION: PPX/carboplatin failed to provide superior survival compared with paclitaxel/carboplatin in the first-line treatment of PS 2 patients with NSCLC, but the results with respect to progression-free survival and overall survival were comparable and the PPX regimen was more convenient.